San Luis Wealth Advisors LLC Abb Vie Inc. Transaction History

San Luis Wealth Advisors LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 12, 2024	SELL	$154.79 - $180.76 $8,668 - $10,122	-56 Reduced 3.95%	1,362 $234,000
Q1 2024 Apr 11, 2024	SELL	$159.82 - $182.1 $15,982 - $18,210	-100 Reduced 6.59%	1,418 $258,000
Q4 2023 Jan 17, 2024	BUY	$137.6 - $154.97 $7,705 - $8,678	56 Added 3.83%	1,518 $235,000
Q3 2023 Oct 31, 2023	BUY	$133.59 - $154.65 $195,308 - $226,098	1,462 New	1,462 $218,000
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $3,181 - $3,663	-22 Reduced 1.49%	1,457 $232,000
Q4 2022 Feb 02, 2023	SELL	$138.31 - $165.87 $22,129 - $26,539	-160 Reduced 9.76%	1,479 $239,000
Q3 2022 Oct 26, 2022	BUY	$134.21 - $153.93 $15,568 - $17,855	116 Added 7.62%	1,639 $220,000
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $1,100 - $1,399	-8 Reduced 0.52%	1,523 $233,000
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $164,475 - $208,108	1,531 New	1,531 $207,000
Q3 2021 Nov 09, 2021	SELL	$106.4 - $120.78 $596,372 - $676,971	-5,605 Closed	0 $0
Q4 2020 Feb 05, 2021	BUY	$80.49 - $108.67 $451,146 - $609,095	5,605 New	5,605 $601,000

3,891

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $325B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of San Luis Wealth Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on San Luis Wealth Advisors LLC with notifications on news.